Voloridge Investment Management, LLC Olema Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $357,116 - $807,012	-175,057 Reduced 94.03%	11,106 $45,000
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $115,509 - $280,014	-29,694 Reduced 13.76%	186,163 $793,000
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $1.89 Million - $6.63 Million	215,857 New	215,857 $2.02 Million

136

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $217M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.